Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

612.71
BATS BZX Real-Time Price
As of 10:56am ET
 -5.97 / -0.96%
Today’s Change
441.00
Today|||52-Week Range
686.62
+26.83%
Year-to-Date
Will Moderna Stock Reach $500?
10:00am / MotleyFool.com - Paid Partner Content
Regeneron (REGN) Antibody Cocktail REGEN-COV Gets WHO Recommendation
Sep 27 / Zacks.com - Paid Partner Content
Breaking Down CRISPR Technology
6:45am / MotleyFool.com - Paid Partner Content
Could AbbVie's New Collaboration Be a Blockbuster?
Sep 27 / MotleyFool.com - Paid Partner Content
3 Big Pharma Stocks Wall Street Thinks Could Soar By At Least 30%
5:55am / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Continental Resources, O'Reilly Automotive, Darling Ingredients and The Mosaic Co
Sep 27 / Zacks.com - Paid Partner Content
Amgen (AMGN) Repatha Gets FDA Nod for Expanded Use in Kids
Sep 27 / Zacks.com - Paid Partner Content
3 Top Biotech Stocks to Buy for the Long Haul
Sep 27 / MotleyFool.com - Paid Partner Content
OPKO (OPK) BLA Review for Growth Hormone Deficiency Drug Delayed
Sep 27 / Zacks.com - Paid Partner Content
Dare (DARE) Begins Study to Treat Vulvar and Vaginal Atrophy
Sep 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close618.68
Today’s open605.53
Day’s range604.20 - 617.76
Volume13,294
Average volume (3 months)753,061
Market cap$68.3B
Data as of 10:56am ET, 09/28/2021

Growth & Valuation

Earnings growth (last year)+68.51%
Earnings growth (this year)+91.12%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+8.06%
P/E ratio11.0
Price/Sales6.54
Price/Book6.20

Competitors

----
----
----
TAKTakeda Pharmaceutica...-0.34-2.00%
Data as of 10:57am ET, 09/28/2021

Financials

Next reporting dateNovember 9, 2021
EPS forecast (this quarter)$9.95
Annual revenue (last year)$8.5B
Annual profit (last year)$3.5B
Net profit margin41.35%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Tarrytown, New York

Forecasts